STRATEC SE
STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG 17.04.2014 20:41 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Financière de l'Echiquier, Paris, France has notified us pursuant to sec. 21 para. 1 WpHG on 17 April 2014, that on 16 April 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 3% and that the percentage of voting rights on that day amounted to 2.96% (348,851 voting rights). 17.04.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Germany Internet: www.stratec.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
Upcoming Events
Event Functions
Additional Functions
04
Sep 24
STRATEC SE
21st Annual Goldman Sachs European Medtech and Healthcare Conference Organized by: Goldman Sachs
Webcasts
No Webcasts found